Vitalhub (TSE:VHI) Director Sells C$258,000.00 in Stock

Key Points

• Vitalhub Corp. Director Steve Garrington sold 20,000 shares at an average price of C$12.90, equating to a total value of C$258,000, resulting in a 25% decrease in his ownership.
• The company's stock is currently trading at C$11.54, reflecting a small decline of 0.5%, with a market capitalization of C$725.06 million.
• Several analysts have recently increased their target prices for Vitalhub shares, with reports ranging from C$15.00 to C$16.00, indicating positive sentiment towards the stock.

Vitalhub Corp. (TSE:VHI - Get Free Report) Director Steve Garrington sold 20,000 shares of Vitalhub stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the completion of the sale, the director owned 60,000 shares of the company's stock, valued at C$774,000. This trade represents a 25.00% decrease in their position.

Vitalhub Stock Down 0.9%

Shares of TSE:VHI traded down C$0.10 during midday trading on Friday, hitting C$11.09. The stock had a trading volume of 134,896 shares, compared to its average volume of 151,120. The company's 50-day moving average price is C$12.67 and its 200-day moving average price is C$11.06. The company has a market capitalization of C$696.78 million, a P/E ratio of 138.63, a price-to-earnings-growth ratio of 1.18 and a beta of 0.93. Vitalhub Corp. has a fifty-two week low of C$8.30 and a fifty-two week high of C$14.64.

Analyst Upgrades and Downgrades

VHI has been the subject of several analyst reports. National Bankshares set a C$16.00 target price on shares of Vitalhub and gave the company an "outperform" rating in a research report on Thursday, August 21st. TD Securities boosted their target price on shares of Vitalhub from C$15.00 to C$16.00 and gave the company a "buy" rating in a research report on Monday, August 11th. Raymond James Financial boosted their target price on shares of Vitalhub from C$14.50 to C$15.00 and gave the company an "outperform" rating in a research report on Tuesday, August 12th. National Bank Financial upgraded shares of Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. Finally, Scotiabank boosted their target price on shares of Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research report on Friday, June 20th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company. Based on data from MarketBeat.com, Vitalhub presently has an average rating of "Buy" and an average price target of C$14.08.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.